In the media
Gilead licenses HIV-prevention drug to generic drugmakers
How a new HIV medicine reduced carbon emissions
Latin America is catching up on HPV vaccination and screening
Wider use of material-saving HIV drug cutting CO2 emissions: Report
World’s leading HIV drug reduces carbon emissions by 26 million tons In comparison to predecessor
Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries
Game-changing HIV shot can’t get to high-risk groups fast enough
HIV trial shows injectable prevents 100% infection in women and girls